Hofseth BioCare ASA posted total operating revenues of NOK 83.5 million in the third quarter of 2026, a 52.1% year-on-year increase from NOK 54.9 million in Q3 2025 and the highest quarterly revenue figure in the company's history. Net operating revenues reached NOK 82.1 million, compared with NOK 54.8 million in the prior-year period.
The Numbers
The gap between total and net operating revenues — NOK 1.4 million — reflects relatively modest deductions, suggesting limited returns or allowances in the quarter. The year-on-year improvement of roughly NOK 27.6 million in gross revenue represents growth of more than 50%, a pace that significantly outstrips typical mid-single-digit expansion rates seen across much of the marine-derived ingredient sector in recent quarters.
Why It Matters
Hofseth BioCare operates at the intersection of aquaculture by-products and functional food ingredients, converting salmon processing waste into high-value bioactive compounds — including marine protein hydrolysates and omega-3 concentrates — sold into nutraceutical, clinical nutrition, and specialty food and beverage formulation channels. Record quarterly revenue signals that demand for sustainably sourced, traceable marine bionutrients is accelerating, as food and beverage manufacturers face growing pressure from retailers and regulators to document the provenance and circular credentials of their ingredient supply chains.
What's Next
The company has not issued formal forward guidance in the materials available, but the trajectory — three consecutive quarters of double-digit year-on-year revenue growth would be consistent with a full-year run-rate meaningfully above prior-year levels. Investors and ingredient buyers will watch whether HBC can sustain margins alongside this volume expansion, particularly given elevated energy and logistics costs that have pressured Norwegian seafood processors broadly through 2025 and into 2026.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
Frequently Asked Questions
What exactly drove Hofseth BioCare's 52% revenue jump in Q3 2026?
Hofseth converted salmon processing waste into marine protein hydrolysates and omega-3 concentrates, hitting NOK 83.5 million in total operating revenue—NOK 27.6 million above Q3 2025. The surge reflects accelerating demand from nutraceutical and specialty food formulators facing retailer and regulatory pressure to source traceable, sustainably-derived bioactive ingredients.
How much of Hofseth's Q3 revenue hit the bottom line versus returns and allowances?
Net operating revenues were NOK 82.1 million against total revenues of NOK 83.5 million, meaning just NOK 1.4 million in deductions. That gap signals minimal returns or allowances—a clean operating picture with almost no friction in the sales channel.
Is 52% growth typical for marine-derived ingredient suppliers right now?
No. The marine bionutrient sector is posting mid-single-digit growth in recent quarters, making Hofseth's 52% year-over-year expansion roughly 5-10x faster than peer performance. This outpacing reflects a structural shift toward circular, traceable ingredient sourcing in food and beverage formulation.
Will Hofseth maintain these margins if it keeps scaling volume?
That's the operating question now. The company has not issued forward guidance, but three consecutive quarters of double-digit YoY growth points to a run-rate well above 2025 levels. Ingredient buyers and investors will scrutinize whether HBC can hold profitability and supply consistency through this expansion.
Who's buying Hofseth's ingredients and why now?
Nutraceutical manufacturers, clinical nutrition companies, and specialty F&B formulators are driving demand for marine protein hydrolysates and omega-3 concentrates sourced from aquaculture by-products. Retailers and regulators are forcing supply-chain transparency and circular credentials, making Hofseth's traceable, waste-conversion model a competitive edge.
